Aug 7, 2018
This episode discusses issues around artificial intelligence & Biopharma R&D IT, and outlines how AI can be a potentially transformative technology for the biopharmaceutical and healthcare industries.
"...R&D productivity remains an ongoing concern. Artificial Intelligence and the accompanying analytics are now so advanced that these tools promise to improve the traditional drug target selection and R&D process." As noted in the Ernst & Young report Beyond borders Biotechnology report 2017 (1).
This article was written by The PRISME Forum
If you'd like to view the original article then follow the link below:
https://www.ddw-online.com/informatics/p322097-artificial-intelligence-&-biopharma-r&d-it.html
You can also download the original article pdf here:
https://www.ddw-online.com/media/32/129238/(1)-artificial-intelligence-and-biopharma-rd-it.pdf
For more information on Drug Discovery World, head to: